10-propargyl-10-deazaaminopterin and 2019 Novel Coronavirus Disease

10-propargyl-10-deazaaminopterin has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Altınay, S; Kural, A; Özmen, A; Tural, D; Tutar, Y	1

Reviews

1 review(s) available for 10-propargyl-10-deazaaminopterin and 2019 Novel Coronavirus Disease

Article	Year
Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind. Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:3 Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States	2023

Article

Year

Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.

Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:3

Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States

2023